These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 9673245)
1. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside. Prendergast MM; Lastovica AJ; Moran AP Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245 [TBL] [Abstract][Full Text] [Related]
2. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. Yuki N; Taki T; Inagaki F; Kasama T; Takahashi M; Saito K; Handa S; Miyatake T J Exp Med; 1993 Nov; 178(5):1771-5. PubMed ID: 8228822 [TBL] [Abstract][Full Text] [Related]
3. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS). Gregson NA; Rees JH; Hughes RA J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756 [TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221 [TBL] [Abstract][Full Text] [Related]
5. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. Yuki N; Handa S; Tai T; Takahashi M; Saito K; Tsujino Y; Taki T J Neurol Sci; 1995 May; 130(1):112-6. PubMed ID: 7544402 [TBL] [Abstract][Full Text] [Related]
6. Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains. Prendergast MM; Kosunen TU; Moran AP J Clin Microbiol; 2001 Apr; 39(4):1494-500. PubMed ID: 11283076 [TBL] [Abstract][Full Text] [Related]
7. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. Yuki N J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700 [TBL] [Abstract][Full Text] [Related]
8. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome. Prendergast MM; Willison HJ; Moran AP Infect Immun; 1999 Jul; 67(7):3698-701. PubMed ID: 10377164 [TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. Prendergast MM; Moran AP J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055 [TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection. Yuki N; Miyatake T Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis. Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134 [TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of Guillain-Barré syndrome and Fisher's syndrome: molecular mimicry between antecedent infectious agents and components of nerve tissues]. Yuki N Rinsho Shinkeigaku; 1995 Dec; 35(12):1373-5. PubMed ID: 8752400 [TBL] [Abstract][Full Text] [Related]
14. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope. Yuki N; Taki T; Takahashi M; Saito K; Tai T; Miyatake T; Handa S Infect Immun; 1994 May; 62(5):2101-3. PubMed ID: 7513313 [TBL] [Abstract][Full Text] [Related]
15. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. Yuki N; Ichihashi Y; Taki T J Neuroimmunol; 1995 Jul; 60(1-2):161-4. PubMed ID: 7543907 [TBL] [Abstract][Full Text] [Related]
16. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits. Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352 [TBL] [Abstract][Full Text] [Related]
17. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome. Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448 [TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608 [TBL] [Abstract][Full Text] [Related]
19. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome. Neisser A; Schwerer B; Bernheimer H; Moran AP J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Yuki N Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]